Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 375

  • Did you mean: nan lu (222 items)
1.

Chemical synthesis of homogeneous granulocyte-macrophage colony-stimulating factor through Se-auxiliary-mediated ligation.

Lu D, Yin H, Wang S, Tang F, Huang W, Wang P.

J Org Chem. 2019 Dec 3. doi: 10.1021/acs.joc.9b02232. [Epub ahead of print]

PMID:
31793779
2.

Stenotrophomonas maltophilia infections: Clinical characteristics in a military trauma population.

Patterson SB, Mende K, Li P, Lu D, Carson ML, Murray CK, Tribble DR, Blyth DM; IDCRP TIDOS Group.

Diagn Microbiol Infect Dis. 2019 Nov 23:114953. doi: 10.1016/j.diagmicrobio.2019.114953. [Epub ahead of print]

PMID:
31791809
3.

Collaborative implementation of stereotactic ablative body radiotherapy: A model for the safe implementation of complex radiotherapy techniques in Australia.

Hau E, Hegi-Johnson F, Atkinson C, Barber J, Browne LH, Chin Y, Dwyer P, Graham PH, O'Hare J, Lu D, Rains M, Ragusa C, Schmidth L, Small K, Unicomb K, West K, White S, Last A, Ludbrook J, Azzi M, Aherne NJ, Van Tilburg K, Vinod S, Ma X, Yeghiaian Alvandi R.

Asia Pac J Clin Oncol. 2019 Nov 27. doi: 10.1111/ajco.13277. [Epub ahead of print]

PMID:
31777176
4.

A clinical research study on the respective relationships between visfatin and human fetuin A and pregnancy outcomes in gestational diabetes mellitus.

Lu D, Yang M, Yao Y, Xie Y.

Taiwan J Obstet Gynecol. 2019 Nov;58(6):808-813. doi: 10.1016/j.tjog.2019.09.015.

5.

Process optimization for simultaneous antibiotic removal and precious metal recovery in an energy neutral process.

Wu D, Lu D, Sun F, Zhou Y.

Sci Total Environ. 2019 Dec 10;695:133914. doi: 10.1016/j.scitotenv.2019.133914. Epub 2019 Aug 14.

PMID:
31756851
6.

Integrated Two-Analyte Population Pharmacokinetic Model of Polatuzumab Vedotin in Patients with Non-Hodgkin Lymphoma.

Lu D, Lu T, Gibiansky L, Li X, Li C, Agarwal P, Shemesh CS, Shi R, Dere RC, Hirata J, Miles D, Chanu P, Girish S, Yan Jin J.

CPT Pharmacometrics Syst Pharmacol. 2019 Nov 20. doi: 10.1002/psp4.12482. [Epub ahead of print]

7.
8.

Detection of Circulating Tumor Cell Molecular Subtype in Pulmonary Vein Predicting Prognosis of Stage I-III Non-small Cell Lung Cancer Patients.

Dong J, Zhu D, Tang X, Qiu X, Lu D, Li B, Lin D, Zhou Q.

Front Oncol. 2019 Oct 29;9:1139. doi: 10.3389/fonc.2019.01139. eCollection 2019.

9.

Exploring a Moderate Fallow Scale of Cultivated Land in China from the Perspective of Food Security.

Lu D, Wang Y, Yang Q, He H, Su K.

Int J Environ Res Public Health. 2019 Nov 6;16(22). pii: E4329. doi: 10.3390/ijerph16224329.

10.

Biotransformation of phosphorus in enhanced biological phosphorus removal sludge biochar.

Qian T, Lu D, Soh YNA, Webster RD, Zhou Y.

Water Res. 2019 Oct 31;169:115255. doi: 10.1016/j.watres.2019.115255. [Epub ahead of print]

PMID:
31698148
11.

Organics transformation and energy production potential in a high rate A-stage system: A demo-scale study.

Cao S, Lu D, Phua K, Yan W, Le C, Tao G, Zhou Y.

Bioresour Technol. 2020 Jan;295:122300. doi: 10.1016/j.biortech.2019.122300. Epub 2019 Oct 18.

PMID:
31669872
12.

Relationship Between Body Mass Index and Recurrence/Anal Fistula Formation Following Initial Operation for Anorectal Abscess.

Lu D, Lu L, Cao B, Li Y, Cao Y, Li Z, Wang Z, Lu J.

Med Sci Monit. 2019 Oct 23;25:7942-7950. doi: 10.12659/MSM.917836.

13.

Exposure-response analysis of venetoclax in combination with rituximab in patients with relapsed or refractory chronic lymphocytic leukemia: pooled results from a phase 1b study and the phase 3 MURANO study.

Deng R, Gibiansky L, Lu T, Li X, Lu D, Li C, Girish S, Wang J, Boyer M, Shankar N, Humphrey K, Freise KJ, Salem AH, Seymour JF, Kater AP, Miles D.

Leuk Lymphoma. 2019 Sep 24:1-10. doi: 10.1080/10428194.2019.1657575. [Epub ahead of print]

PMID:
31549889
14.

The effect of HMG-CoA reductase inhibitors on thrombolysis-induced haemorrhagic transformation.

Wu Y, Lu D, Xu A.

J Clin Neurosci. 2019 Nov;69:1-6. doi: 10.1016/j.jocn.2019.08.074. Epub 2019 Sep 11. Review.

PMID:
31521472
15.

Peptide presentation by bat MHC class I provides new insight into the antiviral immunity of bats.

Lu D, Liu K, Zhang D, Yue C, Lu Q, Cheng H, Wang L, Chai Y, Qi J, Wang LF, Gao GF, Liu WJ.

PLoS Biol. 2019 Sep 9;17(9):e3000436. doi: 10.1371/journal.pbio.3000436. eCollection 2019 Sep.

16.

Overexpression of B7-H3 as an opportunity for targeted therapy in head and neck cancers.

Hu J, Jiang C, Zheng M, Guo Y, Tang X, Ren J, Lu D, Yu L, Gan W, Liu S, Tong A, Yang H.

Am J Transl Res. 2019 Aug 15;11(8):5183-5196. eCollection 2019.

17.

A New Strategy for the Synthesis of Fluorinated Polyurethane.

Wang PC, Lu D, Wang H, Bai RK.

Polymers (Basel). 2019 Sep 2;11(9). pii: E1440. doi: 10.3390/polym11091440.

18.

Publisher Correction: Mapping exclusive breastfeeding in Africa between 2000 and 2017.

Bhattacharjee NV, Schaeffer LE, Marczak LB, Ross JM, Swartz SJ, Albright J, Gardner WM, Shields C, Sligar A, Schipp MF, Pickering BV, Henry NJ, Johnson KB, Louie C, Cork MA, Steuben KM, Lazzar-Atwood A, Lu D, Kinyoki DK, Osgood-Zimmerman A, Earl L, Mosser JF, Deshpande A, Burstein R, Woyczynski LP, Wilson KF, VanderHeide JD, Wiens KE, Reiner RC Jr, Piwoz EG, Rawat R, Sartorius B, Weaver ND, Nixon MR, Smith DL, Kassebaum NJ, Gakidou E, Lim SS, Mokdad AH, Murray CJL, Dwyer-Lindgren L, Hay SI.

Nat Med. 2019 Sep;25(9):1458. doi: 10.1038/s41591-019-0577-1.

19.

Divergent Peptide Presentations of HLA-A*30 Alleles Revealed by Structures With Pathogen Peptides.

Zhu S, Liu K, Chai Y, Wu Y, Lu D, Xiao W, Cheng H, Zhao Y, Ding C, Lyu J, Lou Y, Gao GF, Liu WJ.

Front Immunol. 2019 Jul 23;10:1709. doi: 10.3389/fimmu.2019.01709. eCollection 2019.

20.

Vibrational Therapies for Vocal Fatigue.

Yiu EML, Liu CCY, Chan CYP, Barrett E, Lu D.

J Voice. 2019 Aug 2. pii: S0892-1997(19)30141-9. doi: 10.1016/j.jvoice.2019.07.009. [Epub ahead of print]

PMID:
31383515
  • Did you mean: nan lu (222 items)

Supplemental Content

Loading ...
Support Center